Peroxisome proliferator activated receptors (PPARs) are ligand-activated transcription factors expressed in trophoblasts, which regulate both cell differentiation and proliferation. In recent years, evidence has linked PPARs to playing an integral role in pregnancy; specifically, PPAR-b and PPAR-g have been shown to play an integral role in placentation, with PPAR-g additionally serving to regulate trophoblast differentiation. Recent evidence has shown that PPAR-g expression is altered in many complications of pregnancy such as intrauterine growth restriction (IUGR), preterm birth, pre-clampsia and gestational diabetes. Thus, at present, accumulating evidence from the literature suggests both a pivotal role for PPAR-g in the progression of a healthy pregnancy and the possibility that PPAR-g may act as a therapeutic target in complicated pregnancies. This review aims to provide a succinct and comprehensive assessment of the role of PPAR-g in normal pregnancy and pregnancy complications, and finally its potential as a therapeutic target in the treatment and/or prevention of adverse pregnancy outcomes.
AbbreviationsET-1, endothelin-1; HO-1, heme oxygenase-1; ICAM-1, intercellular adhesion molecule-1; IKK, IkB kinase; RXR, retinoid X receptor; SO, superoxide; TXA2, thromboxane A2; VCAM-1, vascular adhesion molecule-1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.